Average Co-Inventor Count = 3.60
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Tg Therapeutics, Inc. (3 from 7 patents)
2. Laboratoire Francais Du Fractionnement Et Des Biotechnologies (2 from 85 patents)
3. Rhizen Pharmaceuticals Sa (2 from 51 patents)
4. Laboratoire Francais Du Fractionnement Et Das Biotechnologies (1 from 1 patent)
5. Rhizen Pharmaceuticals Na (1 from 1 patent)
3 patents:
1. 10966977 - Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders
2. 10729768 - Combination of anti-CD20 antibody and PI3 kinase selective inhibitor
3. 9694071 - Combination of anti-CD20 antibody and PI3 kinase selective inhibitor